The $17.89 Is The Price At Which Oscar Health Inc (NYSE: OSCR) Deserves Consideration

During the last session, Oscar Health Inc (NYSE:OSCR)’s traded shares were 3.65 million, with the beta value of the company hitting 1.67. At the end of the trading day, the stock’s price was $17.89, reflecting an intraday gain of 1.71% or $0.3. The 52-week high for the OSCR share is $18.55, that puts it down -3.69 from that peak though still a striking 73.62% gain since the share price plummeted to a 52-week low of $4.72. The company’s market capitalization is $4.11B, and the average trade volume was 3.14 million shares over the past three months.

Oscar Health Inc (NYSE:OSCR) trade information

Oscar Health Inc (OSCR) registered a 1.71% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.71% in intraday trading to $17.89, hitting a weekly high. The stock’s 5-day price performance is 8.75%, and it has moved by 28.15% in 30 days. Based on these gigs, the overall price performance for the year is 210.05%.

Oscar Health Inc (OSCR) estimates and forecasts

Statistics show that Oscar Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Oscar Health Inc (OSCR) shares have gone up 251.47% during the last six months, with a year-to-date growth rate more than the industry average at 81.15% against 13.70. In the rating firms’ projections, revenue will increase 42.20% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 2.01B as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 2.1B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 1.15B and 1.52B respectively. In this case, analysts expect current quarter sales to grow by 75.50% and then jump by 37.80% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -2.85%. While earnings are projected to return 87.21% in 2024.

OSCR Dividends

Oscar Health Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Oscar Health Inc (NYSE:OSCR)’s Major holders